Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and artificial intelligence (AI).
Health
Health
Villavicencio.com aims to provide comprehensive news coverage from trusted various sources worldwide. We help people discover interesting content that will inform, entertain, and inspire you. We focus on delivering an engaging news experience.